Form 10-KT/A - Transition reports [Rule 13a-10 or 15d-10]: [Amend]
SEC Accession No. 0000950123-10-102209
Filing Date
2010-11-08
Accepted
2010-11-08 10:29:26
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-KT/A c08034e10vktza.htm 10-KT/A 50855
2 EXHIBIT 10.18 c08034exv10w18.htm EX-10.18 81423
3 EXHIBIT 31.1 c08034exv31w1.htm EX-31.1 5246
4 EXHIBIT 31.2 c08034exv31w2.htm EX-31.2 5228
5 EXHIBIT 32.1 c08034exv32w1.htm EX-32.1 2400
6 EXHIBIT 32.2 c08034exv32w2.htm EX-32.2 2373
  Complete submission text file 0000950123-10-102209.txt   149119
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-KT/A | Act: 34 | File No.: 000-52530 | Film No.: 101171064
SIC: 2836 Biological Products, (No Diagnostic Substances)